Skip to main content

Day: January 3, 2024

Kelly Completes Sale of European Staffing Business to Gi Group Holdings S.P.A.

Sharpens its focus on higher margin, higher growth global managed service provider (MSP) and recruitment process outsourcing (RPO), and North American specialty outcome-based and staffing services Accelerates transformation to deliver significantly improved net margin Cash proceeds to be redeployed in pursuit of growth through organic and inorganic investmentsTROY, Mich., Jan. 03, 2024 (GLOBE NEWSWIRE) —  Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced it has completed the sale of its European staffing business to Gi Group Holdings S.P.A. (“Gi”). Kelly previously announced on November 2, 2023, that it had entered into a definitive agreement to sell the business to Gi. “Today is a significant milestone in Kelly’s journey to become a more focused enterprise positioned to accelerate...

Continue reading

Liquidity Services Acquires Sierra Auction, a Leading Auctioneer of Vehicles, Equipment, and Surplus Assets for Government and Commercial Organizations

Acquisition strengthens and accelerates the company’s position as the leading online platform for the sale of vehicles, equipment, and surplus assets by government and commercial sellers BETHESDA, Md., Jan. 03, 2024 (GLOBE NEWSWIRE) — Liquidity Services, Inc. (NASDAQ: LQDT), a leading global commerce company powering the circular economy, today announced it has acquired Sierra Auction, a full-service auction company specializing in the sale of vehicles, equipment and surplus assets for government agencies, commercial businesses, and charities. Sierra hosts the largest weekly public online auctions in Arizona. The transaction accelerates Liquidity Services’ penetration of the southwest US market for municipal government surplus and expands the size of Liquidity Services’ overall transportation and used equipment footprint. Established...

Continue reading

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees

FREMONT, CA , Jan. 03, 2024 (GLOBE NEWSWIRE) — via NewMediaWire  – ABVC BioPharma, Inc. (NASDAQ: ABVC) and its subsidiary BioLite, Inc. (“Company”), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and its subsidiary received an aggregate of 46 million shares from AiBtl BioPharma Inc. (“AiBtl”), as its first milestone payment under a global licensing agreement. The agreement between the Company and AiBtl placed a value of $460 ($10 per share) on such payment. AiBtl is a private company, and the share value is based on the terms of the agreement between the parties and the valuation report done by an independent third party. The Company entered into a definitive global licensing...

Continue reading

Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference

LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference. The Company is scheduled to present on Thursday, January 11, 2024, at 9:45 a.m. Pacific time (12:45 p.m. Eastern time). A live webcast of the presentation will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived and available for replay for at least 30 days after the event. About Rapid Micro Biosystems Rapid Micro Biosystems is...

Continue reading

Gilat to Participate in the 26th Annual Needham Growth Conference on January 17, 2024

PETAH TIKVA, Israel, Jan. 03, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today announced management’s participation in the 26th Annual Needham Growth Conference taking place at the Lotte New York Palace Hotel in New York City from January 16-19, 2024. Mr. Adi Sfadia, the Company’s CEO, and Mr. Gil Benyamini, the Company’s CFO, will be available for one-on-one meetings with investors at the conference. The company will give a presentation to conference participants on January 17, 2024, at 2:15 pm Eastern Time. To schedule a meeting with management, please contact a Needham representative or email a request to the Gilat investor relations team at gilat@ekgir.com. About Gilat Gilat Satellite Networks Ltd. (NASDAQ:...

Continue reading

Columbus confirms acquisition of Endless Gain

Company announcement no. 1/2024In company announcement no. 25/2023 of 30 November 2023, Columbus A/S announced the acquisition of the UK-based e-commerce consultancy Endless Gain Ltd., which was conditional on fulfilment of a few employee related conditions. These conditions have been fulfilled as expected, and closing of the acquisition has been completed today with effective date 1 January 2024. Expectations to revenue and EBITDA for the Group in 2024 will be announced when the Annual Report 2023 is published on 13 March 2024.For further information, please contact: CEO & President, Søren Krogh Knudsen, +45 70 20 50 00Ib Kunøe                        Søren Krogh KnudsenChairman of the Board                CEO & PresidentAttachmentSE_01_2024_Columbus_confirms_acquisition_of_Endless_Gain

Continue reading

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that the management team will participate and present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 3:00pm EST (12:00 PM PST). Event: 42nd Annual J.P. Morgan Healthcare Conference Date: Thursday, January 11, 2024 Time: 12:00 PM PST A live audio webcast of the conference presentation will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations. Replays of the webcasts will be archived on the website for approximately 30 days. About Asensus Surgical, Inc. Asensus Surgical, Inc. is digitizing the interface between the...

Continue reading

NIO Inc. Announces Repurchase Right Notification for 0.00% Convertible Senior Notes due 2026

SHANGHAI, China, Jan. 03, 2024 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced that it is notifying holders of its 0.00% Convertible Senior Notes due 2026 (CUSIP No. 62914VAE6) (the “Notes”) that pursuant to the Indenture dated as of January 15, 2021 (the “Indenture”) relating to the Notes by and between the Company and The Deutsche Bank Trust Company Americas, as trustee, each holder has the right, at the option of such holder, to require the Company to repurchase all of such holder’s Notes or any portion thereof that is an integral multiple of US$1,000 principal amount for cash on February 1, 2024 (the “Repurchase Right”). The Repurchase Right expires at 5:00 p.m., New York City time, on Wednesday,...

Continue reading

Enovis Completes Acquisition of LimaCorporate S.p.A

WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed the acquisition of LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions.  Lima strengthens Enovis’ position in the global orthopedic reconstruction market with a complementary portfolio of proven surgical solutions and technologies, which will accelerate global growth and margin expansion. In addition, Lima’s portfolio includes 3D printed Trabecular Titanium implants and a comprehensive revision offering in shoulders, which will further strengthen the Company’s position in the fast-growing extremities market.  “We...

Continue reading

Copenhagen Infrastructure Partners acquires early-stage Danish solar PV portfolio from Soltec

Today, Soltec Power Holding and CIP announced CIP’s 100% ownership acquisition of the Soltec Danish solar PV project portfolio. COPENHAGEN, Denmark, Jan. 03, 2024 (GLOBE NEWSWIRE) — CIP’s Energy Transition Fund I (CI ETF I) will obtain 100% ownership of Soltec’s Danish early-stage solar PV portfolio. CIP’s intention is to develop, build and operate these assets to provide renewable electricity for ETF I’s Danish Power-to-X projects (e.g., Fjord eSAF, Høst green ammonia/hydrogen). The portfolio consists of development projects with a combined potential installed capacity of ~850MWDC. The project sites are scattered across Denmark, with the vast majority of the projects situated in Jutland. Felix Pahl, Partner in CIP, commented: “We are proud to have made CIP’s first acquisition of Danish solar PV energy. The Soltec portfolio represents...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.